Illness	Number of cases
Hypertrophy of breast (N62)	188
Malignant neoplasm of breast (C50.9)	181
Gender identity disorders - Transsexualism (F64.0)	180
Complications of other internal prosthetic devices implants and grafts (T85.82)	102
Other disorders of skin and subcutaneous tissue not elsewhere classified - Excessive and redundant skin and subcutaneous tissue (L98.7)	35
Complications of other internal prosthetic devices implants and grafts (T85.4)	34
Hypertrophic disorders of skin - Hypertrophic scar (L91.0)	20
Carcinoma in situ of breast (D05.1)	17
Complications of other internal prosthetic devices implants and grafts (T85.73)	17
Family history of malignant neoplasm - Family history of malignant neoplasm of breast (Z80.3)	14

Top 10 treatments

Treatment	Number
Surgical removal of the breast (mastectomy), without taking the axillary lymph nodes (5-872.1)	255
Operation on the nipple (5-882.2)	193
Surgical breast reduction (5-884.2)	155
Simple surgical closure of the skin or the subcutaneous tissues after injuries, e.g. with a suture (5-900.0b)	119
Reconstructive operation on the breast with skin and muscle grafting (transplantation) (5-885.9)	118
Other operations on the breast (5-889.1)	110
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.2a)	68
Other reconstructive operations on the breast (5-886.x)	65
Temporary covering of soft tissue injuries with skin or artificial skin (5-916.a1)	62
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.1a)	59

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
65	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
46	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
33	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Doctoral supervision